Snake Venom Protease Detection and Inhibition in Serum

Area of Science:

• Biochemistry
• Toxicology
• Biotechnology

Background:

• Snake bites pose significant global health threats, with limited diagnostic tools and treatments.
• Conventional antibody-based antivenoms have limitations in addressing local tissue damage and require complex logistics.

Purpose of the Study:

• To develop sensitive, fluorescence-based assays for detecting snake venom metalloprotease (SVMP) and serine protease (SVSP) activities.
• To evaluate the potential of these assays for diagnosing snakebites and explore small-molecule inhibitors as complementary therapies.

Main Methods:

• Established fluorescence-based assays for SVMP and SVSP activity detection in viper venoms (Crotalus atrox, Bothrops jararaca, Echis carinatus).
• Assessed assay sensitivity and performance in crude venom and biological matrices like bovine and human blood sera.
• Determined the inhibitory effects of various small-molecule protease inhibitors on SVMP and SVSP activities.

Main Results:

• Developed species-specific assays with high sensitivity (sub-microgram detection limits) for SVSP and SVMP.
• Demonstrated successful detection of protease activity in blood sera, indicating clinical relevance.
• Identified potent small-molecule inhibitors (batimastat, marimastat, ilomastat, nafamostat, leupeptin) targeting SVMP or SVSP.

Conclusions:

• Activity-based assays combined with small-molecule inhibitors show promise for rapid snake venom detection and diagnosis.
• This approach could lead to novel complementary therapies for snakebites, particularly beneficial in resource-poor settings.
• Further development could enhance diagnostic capabilities and therapeutic options for snakebite envenoming.